Locus Biosciences
Signal active
Organization
Contact Information
Overview
Locus Biosciences is a developer of a CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease. The company's platform combines the antibacterial power of CRISPR-Cas3 with the efficient, safe delivery of bacterial viruses called bacteriophage, enabling physicians to begin treatment more quickly, resulting in a better medical outcome.
About
Industries
Biotechnology, Biopharma, Therapeutics
Founded
2015
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Locus Biosciences headquartered in United States, North America, operates in the Biotechnology, Biopharma, Therapeutics sector. The company focuses on Biotechnology and has secured $14.2B in funding across 120 round(s). With a team of 51-100 employees, Locus Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Locus Biosciences, raised $35.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
10
Investors
5
Lead Investors
0
Total Funding Amount
$118.7M
Details
3
Locus Biosciences has raised a total of $118.7M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Early Stage Venture | 19.0M | ||
| 2016 | Seed | 1.3M | ||
| 2022 | Early Stage Venture | 35.0M |
Investors
Locus Biosciences is funded by 26 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Johnson & Johnson Robotics and Digital Solutions | - | FUNDING ROUND - Johnson & Johnson Robotics and Digital Solutions | 35.0M |
| Discovery Innovations | - | FUNDING ROUND - Discovery Innovations | 35.0M |
| Locus Biosciences | - | FUNDING ROUND - Locus Biosciences | 35.0M |
| Viking Global Investors | - | FUNDING ROUND - Viking Global Investors | 35.0M |
Recent Activity
There is no recent news or activity for this profile.